The investment firm’s portfolio includes tech-enabled drug discovery startup Insilico and fertility benefits manager Carrot Fertility.
OrbiMed scores more than $4.3B in private investment funds
The investment firm’s portfolio includes tech-enabled drug discovery startup Insilico and fertility benefits manager Carrot Fertility.
